Verrica Pharmaceuticals VRCA Earnings Call Transcripts

NASDAQ VRCA
$3.52 -0.07 (-1.95%)
At close: Nov 10, 2026 · 4:00 PM EST
2 earnings calls on file for Verrica Pharmaceuticals, from Q1 2026 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Verrica Pharmaceuticals Q2 2026 Earnings Call

Aug 6, 2026 5,103 words · 22 min read
  • Jayson RiegerPresident and Chief Executive Officer
  • Noah RosenbergChief Medical Officer
  • John KirbyInterim Chief Financial Officer
  • David ZawitzChief Operating Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Verrica Pharmaceuticals Earnings Call Transcripts

Calls2
LatestAug 6, 2026
SinceQ1 2026

Fiscal 2026

All 2 Verrica Pharmaceuticals transcripts Register to get access to Verrica Pharmaceuticals’s earnings call transcripts.